129
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Prevalence of Spotted Fever Group Rickettsia in North-Eastern Poland

, , , , , & show all
Pages 810-814 | Received 09 Jun 2019, Accepted 22 Aug 2019, Published online: 09 Sep 2019
 

Abstract

Purpose: The north-eastern Poland is an endemic region of tick-borne diseases. The aim of the study is to assess the prevalence of anti-Rickettsia antibodies in the inhabitants of the north-eastern Poland and to assess the risk of acute infection (rickettsiosis) after a tick bite. Other aim was to assess the risk of co-infection with other pathogens after a tick bite.

Methods: Two types of examinations were performed: serological and molecular. Serological analysis was performed in 82 foresters and 82 farmers with a history of tick bite. The molecular study was performed in 540 patients with various symptoms after a tick bite. The control group consisted of 20 honorary blood donors with no tick bites in anamnesis. Anti-Rickettsia spp. antibodies titres were determined by ELISA: Rickettsia SFG IgG ELISA (DRG International Inc. USA). PCR tests were performed towards Rickettsia spp. Borrelia burgdorferi, Anaplasma phagocytophilum.

Results: In 64 (39.02%) farmers and foresters, anti-Rickettsia IgG antibodies were detected. The presence of anti-Rickettsia IgG antibodies was confirmed in 42 foresters (51.22%) and in 22 farmers (26.83%). In control group, results of all tests were negative. Rickettsia spp. DNA has not been confirmed in any out of 540 (0%) symptomatic patients.

Conclusions: Seroprevalence of Rickettsia spp. infection in north-eastern Poland is high, especially in people often bitten by ticks, which makes this pathogen potentially dangerous for humans. Prevalence of anti-Rickettsia IgG antibodies in foresters is higher than in farmers. Symptomatic infection with Rickettsia spp. in humans in north-eastern Poland is uncommon.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

The study was founded by Medical University of Bialystok, SUB/1/DN/19/001/1145.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.